Evidence map›Paper›PMID 42005470›Full record

ArticleCommunications in statistics: Simulation and computation2026

A New Estimation Algorithm for Destructive Cure Model: Illustration with Exponentially Weighted Poisson Competing Risks.

Suvra Pal, Souvik Roy

Abstract read
In one paragraph

Article in Communications in statistics: Simulation and computation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suvra PalDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.
Souvik RoyDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.

Funding

Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional SettingsR35GM156859 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI SUVRA PAL · 2025 to 2026
$643k
Using Machine Learning to Improve the Predictive Accuracy of Disease CureR15GM150091 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI PAL, SUVRA · 2023 to 2023
$452k
NIGMS NIH HHS R15 GM150091NIGMS NIH HHS R35 GM156859
6 · The paper itself

Abstract

We propose an improved estimation method for the destructive cure rate model by introducing a generic maximum likelihood algorithm, the sequential quadratic Hamiltonian (SQH) scheme, which employs a gradient-free optimization approach. The SQH algorithm is applied to the destructive cure model with exponentially weighted Poisson competing risks, and its performance is evaluated through a comprehensive simulation study. Specifically, we compare the model-fitting accuracy of SQH with the recently developed conjugate gradient line search (CGLS) algorithm. Given that the CGLS method has been shown to outperform the widely used expectation-maximization algorithm and other optimization routines available in R (e.g., optim, nlm, and Rcgmin), our focus is on assessing whether the SQH algorithm can offer further improvements. Simulation results show that the SQH algorithm yields parameter estimates with consistently lower bias and root mean square error, resulting in more accurate and precise cure rate estimation. Furthermore, due to its gradient-free nature, the SQH algorithm requires less CPU time than CGLS. These advantages position the SQH algorithm as a preferred estimation method over CGLS for the destructive cure rate model. To demonstrate its practical utility, we apply the SQH algorithm to a well-known melanoma dataset and present the analysis results.

Indexed as

Competing risksCure rateDestructive cure modelLong-term survivorsOptimization

Identifiers

PMID42005470
PMCPMC13089356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.